Number of items: 19.
Improving physical function of patients following intensive care unit admission (EMPRESS): protocol of a randomised controlled feasibility trial -
Rebecca Cusack,
Andrew Bates,
Kay Mitchell,
Zoe van Willigen,
Linda Denehy,
Nicholas Hart,
Ahilanandan Dushianthan,
Isabel Reading,
Maria Chorozoglou,
Gordon Sturmey,
Iain Davey and
Michael Grocott
Type: Article
| 2022
Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney disease -
Hugh G. Gallagher,
Jennifer S. Dumbleton,
Thomas Maishman,
Amy L Whitehead,
Michael Moore,
Ahmet Fuat,
David A. Fitzmaurice,
Robert A. Henderson,
Joanne Lord,
Kathryn E Griffith,
Paul Stevens,
Maarten W. Taal,
Diane Stevenson,
Simon Fraser,
Mark Lown,
Christopher J Hawkey and
Paul Roderick
Type: Article
| 2022
Type: Monograph
| 2022
| British Cochlear Implant Group
Treating Acute EXacerbations of COPD with Chinese HerbAL MedIcine to aid AntiBiotic Use Reduction (EXCALIBUR): study protocol of a randomised double-blind, placebo-controlled feasibility trial -
Xiao-Yang Hu,
Tom Oliver,
Merlin Willcox,
Catherine Simpson,
Kerensa Thorne,
Jeanne Trill,
Nick Francis,
Beth Stuart,
Michael Thomas,
Paul Little,
Jian-Ping Liu,
Gareth Griffiths and
Michael Moore
Type: Article
| 2022
Type: Article
| 2022
| Item not available on this server.
Type: Article
| 2022
| Item availability restricted.
Patient and practitioner priorities and concerns about primary healthcare interactions for osteoarthritis: a meta-ethnography -
Jane Vennik,
Stephanie Hughes,
Kirsten A Smith,
Pranati Misurya,
Jennifer Bostock,
Jeremy Howick,
Christian Mallen,
Paul Little,
Mohana Ratnapalan,
Emily Lyness,
Hajira Dambha-Miller,
Leanne Morrison,
Geraldine Leydon,
Hazel Everitt and
Felicity L Bishop
Type: Review
| 2022
| Item not available on this server.
This list was generated on Tue Oct 8 02:27:35 2024 BST.